Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles

Braverman, 2012 Tuttle, 2013, Selective use of RAI for ablation and adjuvant therapy after total thyroidectomy for differentiated thyroid cancer: a practical approach to clinical decision making, Oral Oncol, 49, 676, 10.1016/j.oraloncology.2013.03.444 Cho, 2015, Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea, Cancer, 121, 259, 10.1002/cncr.29025 Solans, 2001, Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy, J Nucl Med, 42, 738 Lamartina, 2015, Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literature, J Clin Endocrinol Metab, 100, 1748, 10.1210/jc.2014-3882 Jonklaas, 2006, Outcomes of patients with differentiated thyroid carcinoma following initial therapy, Thyroid, 16, 1229, 10.1089/thy.2006.16.1229 Luster, 2008, Guidelines for radioiodine therapy of differentiated thyroid cancer, Eur J Nucl Med Mol Imaging, 35, 1941, 10.1007/s00259-008-0883-1 Haugen, 2016, 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer, Thyroid, 26, 1, 10.1089/thy.2015.0020 Ardito, 2013, Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy, Clin Nucl Med, 38, 25, 10.1097/RLU.0b013e318279bc65 Buffet, 2012, Scoring system for predicting recurrences in patients with papillary thyroid microcarcinoma, Eur J Endocrinol, 167, 267, 10.1530/EJE-12-0105 Jeon, 2016, Radioactive iodine treatment for node negative papillary thyroid cancer with capsular invasion only: results of a large retrospective study, Asia Pac J Clin Oncol, 12, e167, 10.1111/ajco.12159 Nixon, 2011, The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer, Surgery, 150, 1242, 10.1016/j.surg.2011.09.007 Amin, 2017 Andresen, 2017, Radioiodine ablation following thyroidectomy for differentiated thyroid cancer: literature review of utility, dose, and toxicity, Eur Thyroid J, 6, 187, 10.1159/000468927 Sawka, 2004, Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer, J Clin Endocrinol Metab, 89, 3668, 10.1210/jc.2003-031167 Han, 2014, Effects of low-dose and high-dose postoperative radioiodine therapy on the clinical outcome in patients with small differentiated thyroid cancer having microscopic extrathyroidal extension, Thyroid, 24, 820, 10.1089/thy.2013.0362 Wang, 2017, Low activity versus high activity: noninferior response to radioiodine therapy in differentiated patients with extrathyroid extension, Nucl Med Commun, 38, 366, 10.1097/MNM.0000000000000666 Jin, 2015, Characteristics and significance of minimal and maximal extrathyroidal extension in papillary thyroid carcinoma, Oral Oncol, 51, 759, 10.1016/j.oraloncology.2015.05.010 Ito, 2006, Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival, World J Surg, 30, 780, 10.1007/s00268-005-0270-z Kim, 2017, Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma, Oral Oncol, 71, 81, 10.1016/j.oraloncology.2017.06.004 Park, 2018, Long-term prognostic significance of gross extrathyroidal extension invading only strap muscles in patients with differentiated thyroid carcinoma, Br J Surg, 10.1002/bjs.10830 Haymart, 2017, Controversies in the management of low-risk differentiated thyroid cancer, Endocr Rev, 38, 351, 10.1210/er.2017-00067 Iyer, 2011, Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy, Cancer, 117, 4439, 10.1002/cncr.26070 Cheng, 2013, Low- or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: a meta-analysis, J Clin Endocrinol Metab, 98, 1353, 10.1210/jc.2012-3682 Maenpaa, 2008, Low vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study, PLoS One, 3, e1885, 10.1371/journal.pone.0001885 Seo, 2017, Low-dose radioactive iodine ablation is sufficient in patients with small papillary thyroid cancer having minor extrathyroidal extension and central lymph node metastasis (T3 N1a), Clin Nucl Med, 42, 842, 10.1097/RLU.0000000000001812 Pacini, 2006, European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium, Eur J Endocrinol, 154, 787, 10.1530/eje.1.02158 Austin, 2015, Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies, Stat Med, 34, 3661, 10.1002/sim.6607